PET Scan of Brain Metabolism in Relation to Age and Disease
NCT00001972 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 123
Last updated 2008-03-04
Summary
The main source of energy for the brain comes from a combination of oxygen and glucose (sugar). For brain cells to function normally they must receive a constant supply of these nutrients. As areas of the brain become more active blood flow into and out of these areas increase.
In addition to oxygen and glucose, the brain uses chemical compounds known as phospholipids. These phospholipids make up the covering of nerve cells that assist in the transfer of information from cell to cell. Without phospholipids brain cell activity may become abnormal and cause problems in the nervous system.
Certain diseases like Alzheimer's disease and brain tumors can affect blood flow to the brain and change the way the brain metabolizes phospholipids. In addition to diseases, changes in the brain occur with normal healthy aging.
This study is designed to use PET scan to measure changes in blood flow and changes in phospholipid metabolism. Using this technique, researchers can improve their understanding of how certain diseases change the shape and function of the brain.
Conditions
- Alzheimer's Disease
- Brain Neoplasm
- Niemann Pick Disease
Interventions
- DRUG
-
15 O Water
Sponsors & Collaborators
-
National Institute of Neurological Disorders and Stroke (NINDS)
lead NIH
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 1994-09-30
- Completion
- 2002-08-31
Countries
- United States
Study Locations
More Related Trials
-
Modeling the Relationships Between Functional Connectivity and Amyloid Deposition in Alzheimer's Disease
NCT04174287 ·Status: UNKNOWN ·Phase: PHASE2
-
PET Whole Body Biodistribution and Test Retest Bain Imaging Studies Using a Phosphodiesterase 4 Inhibitor (R)-[11C]Rolipram
NCT00250172 ·Status: COMPLETED ·Phase: PHASE1
-
Additional Positron Emission Tomography (PET) Scan of Brain in Patients Undergoing PET Scan for Diseases Unrelated to Brain
NCT00729092 ·Status: COMPLETED
-
Brain Imaging in Elderly People and Individuals With Alzheimer's Disease
NCT00001917 ·Status: COMPLETED
-
Glucose Metabolic, Amyloid, and Tau Brain Imaging in Down Syndrome and Dementia
NCT00966017 ·Status: UNKNOWN
-
PET Imaging of DHA Metabolism
NCT00074503 ·Status: COMPLETED
-
Evaluating the Remote Effects of Stroke With MRI and PET Scans
NCT00063180 ·Status: COMPLETED
-
PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease
NCT04396873 ·Status: RECRUITING ·Phase: PHASE1
-
Developing Advanced MRI Methods for Detecting the Impact of Nutrients on Infant Brain Development
NCT02058225 ·Status: COMPLETED
-
PET Evaluation of Brain Peripheral Benzodiazepine Receptors Using [11C]PBR28 in Frontotemporal Dementia
NCT00613119 ·Status: COMPLETED
-
Ketones Influence on Glucose Metabolism in Brain. A Human Positron Emission Tomography (PET) Study
NCT02357550 ·Status: COMPLETED ·Phase: NA
-
Study of New Magnetic Resonance Imaging Methods of the Brain
NCT00004577 ·Status: RECRUITING
-
Safety and Efficacy of Positron Emission Tomography (PET) Imaging With MNI-558
NCT01217021 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Molecular Cerebral Imaging in Incipient Dementia (MCI-ID) II
NCT02317250 ·Status: WITHDRAWN ·Phase: PHASE3
-
PET Imaging of Phosphodiesterase-4 (PDE4) in Brain and Peripheral Organs of McCune-Albright Syndrome
NCT02743377 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
PET Changes in Alzheimer's Disease (AD)
NCT00094913 ·Status: UNKNOWN
-
Prediction of Dementia in Parkinson's Disease by Measuring Cerebral Metabolism With PET Scan
NCT02855021 ·Status: UNKNOWN ·Phase: NA
-
Peripheral Benzodiazepine Receptors (PBR28) Brain PET Imaging With Lipopolysaccharide Challenge for the Study of Microglia Function in Alzheimer's Disease
NCT04057807 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Study of Cerebral Glucose Metabolism in Neurodegenerative Diseases and Head Trauma
NCT06180213 ·Status: COMPLETED
-
PET Study of Cerebral Metabolism of 11C-acetoacetate and 18F-FDG in Patients Under Moderate Ketosis
NCT02409784 ·Status: COMPLETED ·Phase: NA
-
BOLD Functional Magnetic Resonance Imaging (fMRI) and Cerebral Blood Flow Measurements as Biomarkers for Cognition Enhancing Drugs (3134-006)
NCT00887601 ·Status: COMPLETED ·Phase: PHASE1
-
PET Scan in Patients With Neurocardiologic Disorders
NCT00001418 ·Status: COMPLETED
-
Traumatic Brain Injury and Risk for Chronic Traumatic Encephalopathy
NCT02003183 ·Status: COMPLETED
-
A Study to Investigate the Regional Brain Kinetics of the Positron Emission Tomography Ligand 11C-MK-3168 and the Blocking of the Retention of the Ligand in the Human Brain by JNJ-42165279
NCT02169973 ·Status: COMPLETED ·Phase: PHASE1
-
PET Imaging of Neuroinflammation in Neurodegenerative Diseases Via a Novel Translocator Protein (TSPO) Radioligand
NCT03958630 ·Status: TERMINATED ·Phase: PHASE1